Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BIVI is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
0 top institutions tracked
Sentiment: bullish
Last trade: buy 47 days ago
Red flags: 9
35 filers reported a long position in BIVI for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| MORGAN STANLEY | $1.2M | 605.5K | +704.9% |
| Diametric Capital, LP | $497.9K | 256.6K | -30.6% |
| RENAISSANCE TECHNOLOGIES LLC | $248.2K | 127.9K | +88.3% |
| CITADEL ADVISORS LLC | $186.1K | 96K | +111.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | $137.6K | 70.9K | -15.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $137.3K | 70.8K | -16% |
| PHILADELPHIA TRUST CO | $97K | 50K | -33.3% |
| VANGUARD FIDUCIARY TRUST CO | $72.9K | 37.6K | Unchanged |
| JANE STREET GROUP, LLC | $69.6K | 35.9K | +57.3% |
| PRELUDE CAPITAL MANAGEMENT, LLC | $63.2K | 32.6K | -64.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.